XTL Biopharmaceuticals Appoints CEO Noam Band to Board as Doron Turjeman Resigns

Reuters
2025.10.23 20:00
portai
I'm PortAI, I can summarize articles.

XTL Biopharmaceuticals Ltd. has announced the resignation of Doron Turjeman from the Board of Directors, effective October 21, 2025, due to personal reasons. Noam Band, the current CEO, has been appointed to the Board immediately following this change.

XTL Biopharmaceuticals Ltd. has announced that Doron Turjeman has resigned from the Board of Directors effective October 21, 2025, due to personal reasons. Noam Band, the company’s Chief Executive Officer, has been appointed to the Board in his place, effective immediately. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. XTL Biopharmaceuticals Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-101642), on October 23, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer